L2 Diagnostics
PrivateLast Round
Grant
Aug 1, 2025
Total Funding Raised
$954,451
Company Overview
L2 Diagnostics is a biotechnology company offering innovative diagnostic services for systemic lupus erythematosus and Lyme disease, while also developing diagnostic tools, new vaccines, and small molecule therapeutics across various medical areas.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Defense Tech
Business Model
B2G
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
L2 Diagnostics Comps
Public and private peers based on sector, stage, and business model.
L2 Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 1, 2025 | ||||
| Grant | Jun 19, 2018 | ||||
| Grant | Sep 22, 2015 |
L2 Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Allergy and Infectious Diseases | Grant |
| NIH RADx | Grant |
L2 Diagnostics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about L2 Diagnostics's valuation, stock price, and market status.
